{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:53:44Z","timestamp":1790610824512,"version":"4.1.0"},"reference-count":38,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2024,5,3]]},"DOI":"10.1080\/14740338.2024.2328321","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T06:23:05Z","timestamp":1712816585000},"page":"581-591","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["A real\u2011world pharmacovigilance study of FDA adverse event reporting system events for daratumumab"],"prefix":"10.1080","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0317-6025","authenticated-orcid":false,"given":"Xiaolin","family":"Yun","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danna","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongshi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009576"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0282-1"},{"key":"e_1_3_6_5_1","first-page":"70","article-title":"Darzalex (Daratumumab): first anti-CD38 monoclonal antibody approved for patients with relapsed multiple myeloma","volume":"9","author":"Raedler LA.","year":"2016","unstructured":"Raedler LA. Darzalex (Daratumumab): first anti-CD38 monoclonal antibody approved for patients with relapsed multiple myeloma. Am Health Drug Benefits. 2016;9(Spec Feature):70\u201373.","journal-title":"Am Health Drug Benefits"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.138"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0536-1"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-3192"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014613"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01120-4"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02734"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00940"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01440-x"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103211"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02635-6"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S365513"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107498"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506348"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac574"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/20406207211035272"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13532"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606038"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000000995"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2021.101079"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001562"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2019.1427"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.08.030"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-019-03877-7"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2008.00108"},{"key":"e_1_3_6_30_1","unstructured":"Janssen Biotech Inc. Darzalex product monograph. 2022 [cited 2022 Apr 27]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/761036s041lbl.pdf"},{"key":"e_1_3_6_31_1","unstructured":"Janssen Biotech Inc. Darzalex faspro product monograph. 2022 [cited 2022 Apr 27]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/761145s012lbl.pdf"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004436"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606038"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S365657"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020471"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12349"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2014.11.034"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.14309\/crj.2018.48"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2434-7"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17071"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2024.2328321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:44:24Z","timestamp":1727225064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2024.2328321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,3]]}},"alternative-id":["10.1080\/14740338.2024.2328321"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2024.2328321","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-08-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}